These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5505243)

  • 1. [Use of nerobol in combination with potassium salts in patients with chronic coronary insufficiency].
    Leshchinskiĭ LA; Kharitonova VV
    Klin Med (Mosk); 1970 Oct; 48(10):38-42. PubMed ID: 5505243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined therapeutic use of nerobol and potassium salts in ischemic heart disease].
    Leschinskiĭ LA; Kharitonova VV
    Ter Arkh; 1972 Sep; 44(9):40-4. PubMed ID: 4660401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of nerobol on the contractile capacity of the myocardium].
    Beĭ PI
    Klin Med (Mosk); 1972 Jan; 50(1):69-74. PubMed ID: 5020033
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anabolic steroid nerobol in the therapy of patients with chronic coronary insufficiency].
    Leshchinskiĭ LA; Pevchikh VV; Petrov NM; Kharitonova VV
    Kardiologiia; 1970; 10(4):32-6. PubMed ID: 5497922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of curantyl in combination with potassium-containing preparations in chronic ischemic heart disease].
    Vasilevskiĭ VV; Neĭko EM; Debenko MV
    Klin Med (Mosk); 1976 Feb; 54(2):40-2. PubMed ID: 1271716
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of coronary insufficiency patients with panangin].
    Kuz'ko NV
    Vrach Delo; 1972 Jun; 6():79-83. PubMed ID: 5043617
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of anabolic preparations in atherosclerotic cardiosclerosis].
    Agapova EN; Tkachenko AM; Krutovskaia OV
    Klin Med (Mosk); 1974 Jan; 52(1):42-4. PubMed ID: 4466884
    [No Abstract]   [Full Text] [Related]  

  • 9. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
    Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
    [No Abstract]   [Full Text] [Related]  

  • 10. [Silabolin in the treatment of patients with chronic circulatory insufficiency].
    Bondarenko IP
    Vrach Delo; 1986 Jun; (6):20-3. PubMed ID: 3529620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of milurite in ischemic heart disease].
    Teslenko VG; Khimenko LP
    Vrach Delo; 1980 Oct; (10):18-21. PubMed ID: 7434694
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anabolic agents in the therapy of chronic circulatory failure].
    Bondarenko IP
    Vrach Delo; 1982 Sep; (9):52-5. PubMed ID: 6758353
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral administration of a polarizing mixture in patients with coronary insufficiency].
    Masior J; Zgórniak M
    Przegl Lek; 1966; 22(5):387-90. PubMed ID: 5911970
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
    Girina NI
    Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of anabolic steroids and adrenergic beta receptor blockaders on the indicators of rheogram of the aorta and lungs in patients with ischemic heart disease].
    Sharlaĭ IR
    Vrach Delo; 1974 Aug; 0(8):15-7. PubMed ID: 4153197
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of metabolically active agents in ischemic heart disease patients].
    Denisiuk VI
    Vrach Delo; 1986 Aug; (8):11-4. PubMed ID: 3776144
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrolyte therapy of coronary insufficiency in the practice].
    Menzel M
    Landarzt; 1968 Jul; 44(20):993-5. PubMed ID: 5717732
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of Nerobol in the treatment of patients with rheumatic heart disease and circulatory insufficiency].
    Beĭ PI
    Klin Med (Mosk); 1968 Jun; 46(6):104-6. PubMed ID: 5710561
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical assessment of the use of strophanthin and Nerobol in cardiac insufficiency].
    Polishchuk MA
    Klin Med (Mosk); 1970 Feb; 48(2):53-6. PubMed ID: 5425983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.